Agilent Technologies Stock News

The global Pharmaceutical Lab Equipment market is expected to reach US$ 12.2 Billion by 2027, with a CAGR of 5.4% from 2021 to 2027. The increasing number of research activities in the pharmaceutical and biotechnology industries, the growing need for

Agilent Technologies (NYSE:A) updated its first quarter 2022 earnings guidance on Monday. The company provided earnings per share guidance of $1.160-$1.180 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.020. The company issued revenue guidance of $1.64 billion-$1.66 billion, compared to the consensus revenue estimate of $1.47 billion.Agilent Technologies […]

S.E.E.D. Planning Group LLC decreased its holdings in Agilent Technologies, Inc. (NYSE:A) by 29.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,170 shares of the medical research company’s stock after selling 7,410 shares during the quarter. Agilent Technologies makes up 1.4% of […]

Chevy Chase Trust Holdings Inc. decreased its holdings in Agilent Technologies, Inc. (NYSE:A) by 3.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 187,609 shares of the medical research companys stock after selling 7,197 shares during the period. Chevy Chase Trust []

Some of the major vacuum pumps market players are Leybold GmbH, ULVAC Inc., Gardner Denver, Agilent Technologies Inc., Pfeiffer Vacuum Technology AG, Gebr. Becker GmbH, and Atlas Copco. Some of the major vacuum pumps market players are Leybold GmbH, ULVAC Inc., Gardner Denver, Agilent Technologies Inc., Pfeiffer Vacuum Technology AG, Gebr. Becker GmbH, and Atlas Copco.

Another factual information on the "Global Biodetection Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall

Sciencast Management LP lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 323.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,461 shares of the medical research companys stock after acquiring an additional 16,392 shares during the period. Agilent []

Sciencast Management LP grew its position in Agilent Technologies, Inc. (NYSE:A) by 323.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,461 shares of the medical research companys stock after buying an additional 16,392 shares during the quarter. []

Agilent Technologies, Inc. (NYSE:A) VP Rodney Gonsalves sold 669 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 30th. The stock was sold at an average price of $152.04, for a total transaction of $101,714.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is []

Robeco Institutional Asset Management B.V. trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 10.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,055,958 shares of the medical research company’s stock after selling 122,787 shares during the period. Robeco Institutional Asset Management […]

Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts.

DUBLIN, Dec. 2, 2021 /PRNewswire/ -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis - 2022 to 2026 " report has been added to ResearchAndMarkets.com''s offering. The COVID

According to the report, The global soil testing equipment market size was valued at $3.05 billion in 2020 and is expected to reach $6.99 billion by 2028 growing at the CAGR of 10.63% from 2021 to 2028. There are a

The global mycoplasma infections diagnostics market is consolidated to a large extent with the leading five vendors jointly accounting for 68.0 % of the global market in 2016, notes Transparency Market Research (TMR). The leading companies are Lonza Group, Agilent